Implantable Biohybrid Artificial Organs

Biohybrid artificial organs encompass all devices which substitute for an organ or tissue function and incorporate both synthetic materials and living cells. This review concerns implantable immunoisolation devices in which the tissue is protected from immune rejection by enclosure within a semiperm...

Full description

Bibliographic Details
Main Author: Clark K. Colton
Format: Article
Language:English
Published: SAGE Publishing 1995-07-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/096368979500400413
id doaj-90b74b65ef7d44f68fb1b09d83af20de
record_format Article
spelling doaj-90b74b65ef7d44f68fb1b09d83af20de2020-11-25T02:59:18ZengSAGE PublishingCell Transplantation0963-68971555-38921995-07-01410.1177/096368979500400413Implantable Biohybrid Artificial OrgansClark K. Colton0Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Room 66-452, Cambridge, MA 02139-4307, USABiohybrid artificial organs encompass all devices which substitute for an organ or tissue function and incorporate both synthetic materials and living cells. This review concerns implantable immunoisolation devices in which the tissue is protected from immune rejection by enclosure within a semipermeable membrane. Two critical areas are discussed in detail: (i) Device design and performance as it relates to maintenance of cell viability and function. Attention is focussed on oxygen supply limitation and how it is affected by tissue density and the development of materials that induce neovascularization at the host tissue-membrane interface; and (ii) Protection from immune rejection. Our current knowledge of the mechanisms that may be operative in immune rejection in the presence of a semipermeable membrane barrier is limited. Nonetheless, recent studies shed light on the role played by membrane properties in preventing immune rejection, and many studies demonstrate substantial progress towards clinically useful implantable immunoisolation devices.https://doi.org/10.1177/096368979500400413
collection DOAJ
language English
format Article
sources DOAJ
author Clark K. Colton
spellingShingle Clark K. Colton
Implantable Biohybrid Artificial Organs
Cell Transplantation
author_facet Clark K. Colton
author_sort Clark K. Colton
title Implantable Biohybrid Artificial Organs
title_short Implantable Biohybrid Artificial Organs
title_full Implantable Biohybrid Artificial Organs
title_fullStr Implantable Biohybrid Artificial Organs
title_full_unstemmed Implantable Biohybrid Artificial Organs
title_sort implantable biohybrid artificial organs
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 1995-07-01
description Biohybrid artificial organs encompass all devices which substitute for an organ or tissue function and incorporate both synthetic materials and living cells. This review concerns implantable immunoisolation devices in which the tissue is protected from immune rejection by enclosure within a semipermeable membrane. Two critical areas are discussed in detail: (i) Device design and performance as it relates to maintenance of cell viability and function. Attention is focussed on oxygen supply limitation and how it is affected by tissue density and the development of materials that induce neovascularization at the host tissue-membrane interface; and (ii) Protection from immune rejection. Our current knowledge of the mechanisms that may be operative in immune rejection in the presence of a semipermeable membrane barrier is limited. Nonetheless, recent studies shed light on the role played by membrane properties in preventing immune rejection, and many studies demonstrate substantial progress towards clinically useful implantable immunoisolation devices.
url https://doi.org/10.1177/096368979500400413
work_keys_str_mv AT clarkkcolton implantablebiohybridartificialorgans
_version_ 1724703118355070976